Within retrospective studies of patients with R/R MM who underwent ide-cel therapy, extramedullary disease, prior BCMA targeted therapy, elevated inflammatory markers (including ferritin and C-reactive protein), plasma cell leukemia, and t(4;14) have all been associated with worse PFS [20,21]. Here, CRP is linked to plasma cell leukemia.